<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08032472034803</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid pediatric</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034803</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:38.964Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034797</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid pediatric</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034797</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:32.952Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034780</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034780</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:31.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034766</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid pediatric</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034766</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:30.541Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034759</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid pediatric</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034759</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:29.344Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034285</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034285</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:23.339Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034261</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034261</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:22.139Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034230</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034230</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:20.945Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034223</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034223</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:19.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472034155</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472034155</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:12.550Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472033110</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472033110</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:11.341Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472033097</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472033097</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:10.154Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472033073</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472033073</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:08.938Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472033059</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472033059</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:03.036Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472033035</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472033035</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:29:00.532Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472033011</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472033011</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:28:59.330Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472032991</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Kinder</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472032991</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:28:58.145Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472032977</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472032977</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:28:52.127Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472032939</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472032939</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:28:50.924Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472032922</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472032922</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:28:49.726Z</lastUpdated>
  </row>
</eudamedExport>